Anita H. Lewin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anita H. Lewin has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- S. Wayne Mascarella
Research Triangle Institute , P.O. Box 12194, Research Triangle Park , North Carolina 27709 , United States
8 shared publications - Frank Ivy Carroll
Research Triangle Institute , P.O. Box 12194, Research Triangle Park , North Carolina 27709 , United States
7 shared publications P. Anantha Reddy
Research Triangle Institute , P.O. Box 12194, Research Triangle Park , North Carolina 27709 , United States
4 shared publicationsF. Ivy Carroll
3 shared publications- Herbert H. Seltzman
Research Triangle Institute, P.O. Box 12194, Research Triangle Park, NC 27709, United States
3 shared publications John W. Boja
3 shared publications
Latest Publications
- Open Access
- 26 July 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (31) , 28185-28195
Isolation of Hemiketal and Hydroxy Ketone Tautomers of Synthetic Intermediates Each Affording 18-Hydroxycortisol-1,6,7-d3
During the synthesis of deuterated 18-hydroxycortisol,two of thesynthetic intermediates have been found to exist in tautomeric formsas the acyclic 18-hydroxy 20-ketone and the cyclic 18,20-hemiketalcorresponding to the previously identified less polar (L) and morepolar (M) forms of C-18 hydroxylated steroids, respectively. Specifically, p-chloranil oxidation of 18-hydroxycortisol-17,21-acetonideafforded two isomers of the 6,7-dehydro analogue; separate catalyticreduction of each isomer under deuterium gave a single isomer of acetonide-protected18-hydroxycortisol-1,6,7-d ( 3 ) for each, with the more polar isomer giving a more polar productand the less polar isomer giving a less polar product. The more polarproduct (corresponding to M) was characterized as 18,20-hemiketal;18-hydroxycortisol-17,21-acetonide-18,20-hemiketal-1,6,7-d ( 3 ): in the deuterochloroform solution,it was found to slowly convert to a substance consistent with thehydroxy ketone structure with features resembling those of the isolatedless polar isomer (corresponding to L). Deacetonidization of eachgave 18-hydroxycortisol as a single product, which was characterizedas the 18,20-hemiketal. The issues associated with the existence of18-hydroxysteroids as hydroxy ketones and hemiketals, both in solutionand as isolable solids, are discussed.
- 26 July 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (31) , 28185-28195
Open AccessIsolation of Hemiketal and Hydroxy Ketone Tautomers of Synthetic Intermediates Each Affording 18-Hydroxycortisol-1,6,7-d3
During the synthesis of deuterated 18-hydroxycortisol,two of thesynthetic intermediates have been found to exist in tautomeric formsas the acyclic 18-hydroxy 20-ketone and the cyclic 18,20-hemiketalcorresponding to the previously identified less polar (L) and morepolar (M) forms of C-18 hydroxylated steroids, respectively. Specifically, p-chloranil oxidation of 18-hydroxycortisol-17,21-acetonideafforded two isomers of the 6,7-dehydro analogue; separate catalyticreduction of each isomer under deuterium gave a single isomer of acetonide-protected18-hydroxycortisol-1,6,7-d ( 3 ) for each, with the more polar isomer giving a more polar productand the less polar isomer giving a less polar product. The more polarproduct (corresponding to M) was characterized as 18,20-hemiketal;18-hydroxycortisol-17,21-acetonide-18,20-hemiketal-1,6,7-d ( 3 ): in the deuterochloroform solution,it was found to slowly convert to a substance consistent with thehydroxy ketone structure with features resembling those of the isolatedless polar isomer (corresponding to L). Deacetonidization of eachgave 18-hydroxycortisol as a single product, which was characterizedas the 18,20-hemiketal. The issues associated with the existence of18-hydroxysteroids as hydroxy ketones and hemiketals, both in solutionand as isolable solids, are discussed.
- 1 August 2021
- Published by Elsevier in Bioorganic Chemistry
- Vol. 113, 104955
α-[Amino(4-aminophenyl)thio]methylene-2-(trifluoromethyl)benzeneacetonitrile; Configurational equilibria in solution
- 1 August 2021
- Published by Elsevier in Bioorganic Chemistry
- Vol. 113, 104955
α-[Amino(4-aminophenyl)thio]methylene-2-(trifluoromethyl)benzeneacetonitrile; Configurational equilibria in solution
- 12 May 2020
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1489 (1) , 48-77
Designer drugs: a medicinal chemistry perspective (II)
During 2012–2018, the clandestine manufacture of new psychoactive substances (NPS) designed to circumvent substance control regulations increased exponentially worldwide, with concomitant increase in fatalities. This review focuses on three compound classes identified as synthetic opioids, synthetic amphetamines, and synthetic cannabinoids and highlights the medicinal chemistry precedents utilized by clandestine laboratories to develop new NPS with increased brain penetration, longer duration of action, and greater potency. Chemical approaches to illicit drug abuse treatment options, particularly for opioid use disorder, are also discussed.
- 12 May 2020
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1489 (1) , 48-77
Designer drugs: a medicinal chemistry perspective (II)
During 2012–2018, the clandestine manufacture of new psychoactive substances (NPS) designed to circumvent substance control regulations increased exponentially worldwide, with concomitant increase in fatalities. This review focuses on three compound classes identified as synthetic opioids, synthetic amphetamines, and synthetic cannabinoids and highlights the medicinal chemistry precedents utilized by clandestine laboratories to develop new NPS with increased brain penetration, longer duration of action, and greater potency. Chemical approaches to illicit drug abuse treatment options, particularly for opioid use disorder, are also discussed.
- 29 August 2018
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 10 (1) , 246-251
Synthesis and Characterization of the Selective, Reversible PKCβ Inhibitor (9S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione, Ruboxistaurin (LY333531)
The demonstrated role of PKCβ in mediating amphetamine-stimulated dopamine efflux, which regulates amphetamine-induced dopamine transporter trafficking and activity, has promoted the research use of the selective, reversible PKCβ inhibitor (9S)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione, ruboxistaurin. Despite the interest in development of ruboxistaurin as the mesylate monohydrate (Arxxant) for the treatment of diabetic retinopathy, macular edema, and nephoropathy, several crucial details in physicochemical characterization were erroneous or missing. This report describes the synthesis and full characterization of ruboxistaurin free base (as a monohydrate), including X-ray crystallography to confirm the absolute configuration, and of the mesylate salt, isolated as a hydrate containing 1.5 mol of water per mole.
- 29 August 2018
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 10 (1) , 246-251
Synthesis and Characterization of the Selective, Reversible PKCβ Inhibitor (9S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione, Ruboxistaurin (LY333531)
The demonstrated role of PKCβ in mediating amphetamine-stimulated dopamine efflux, which regulates amphetamine-induced dopamine transporter trafficking and activity, has promoted the research use of the selective, reversible PKCβ inhibitor (9S)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione, ruboxistaurin. Despite the interest in development of ruboxistaurin as the mesylate monohydrate (Arxxant) for the treatment of diabetic retinopathy, macular edema, and nephoropathy, several crucial details in physicochemical characterization were erroneous or missing. This report describes the synthesis and full characterization of ruboxistaurin free base (as a monohydrate), including X-ray crystallography to confirm the absolute configuration, and of the mesylate salt, isolated as a hydrate containing 1.5 mol of water per mole.
- 26 July 2018
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 16 (31) , 5684-5690
Synthesis and physicochemical characterization of (6S)-5-formiminotetrahydrofolate; a reference standard for metabolomics
The one-carbon carrier of the formate oxidation level derived from the interaction of tetrahydrofolate and formiminoglutamate, which has been tentatively identified as 5-formiminoltetrahydrofolate, has been prepared by chemical synthesis. Treatment of a solution of (6S)-tetrahydrofolate in aqueous base with excess ethyl formimidate in the presence of anti-oxidant under anaerobic conditions afforded a gummy solid which, based on mass spectral analysis, conformed to a monoformimino derivative of tetrahydrofolate. Further physicochemical characterization by validated methods strongly suggested that the product of chemical synthesis was identical to the enzymatically produced material and that it was, in fact, (6S)-5-formiminotetrahydrofolate. Conditions and handling methods toward maintaining the integrity of this highly sensitive compound were identified and are described, as is analytical methodology, useful for research studies using it.
- 26 July 2018
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 16 (31) , 5684-5690
Synthesis and physicochemical characterization of (6S)-5-formiminotetrahydrofolate; a reference standard for metabolomics
The one-carbon carrier of the formate oxidation level derived from the interaction of tetrahydrofolate and formiminoglutamate, which has been tentatively identified as 5-formiminoltetrahydrofolate, has been prepared by chemical synthesis. Treatment of a solution of (6S)-tetrahydrofolate in aqueous base with excess ethyl formimidate in the presence of anti-oxidant under anaerobic conditions afforded a gummy solid which, based on mass spectral analysis, conformed to a monoformimino derivative of tetrahydrofolate. Further physicochemical characterization by validated methods strongly suggested that the product of chemical synthesis was identical to the enzymatically produced material and that it was, in fact, (6S)-5-formiminotetrahydrofolate. Conditions and handling methods toward maintaining the integrity of this highly sensitive compound were identified and are described, as is analytical methodology, useful for research studies using it.
- 20 November 2017
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 9 (3) , 563-567
Caged Naloxone: Synthesis, Characterization, and Stability of 3-O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX)
The photolabile analogue of the broad-spectrum opioid antagonist naloxone, 3-O-(4,5-dimethoxy-2-nitrophenyl)carboxymethyl naloxone (also referred to as “caged naloxone”, 3-O-(α-carboxy-6-nitroveratryl)naloxone, CNV-NLX), has been found to be a valuable biochemical probe. While the synthesis of CNV-NLX is simple, its characterization is complicated by the fact that it is produced as a mixture of αR,5R,9R,13S,14S and αS,5R,9R,13S,14S diastereomers. Using long-range and heteronuclear NMR correlations, the 1H NMR and 13C NMR resonances of both diastereomers have been fully assigned, confirming the structures. Monitoring of solutions of CNV-NLX in saline buffer, in methanol, and in DMSO has shown CNV-NLX to be stable for over a week under fluorescent laboratory lights at room temperature. Exposure of such solutions to λ 365 nm from a hand-held UV lamp led to the formation of naloxone and CNV-related breakdown products.
- 20 November 2017
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 9 (3) , 563-567
Caged Naloxone: Synthesis, Characterization, and Stability of 3-O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX)
The photolabile analogue of the broad-spectrum opioid antagonist naloxone, 3-O-(4,5-dimethoxy-2-nitrophenyl)carboxymethyl naloxone (also referred to as “caged naloxone”, 3-O-(α-carboxy-6-nitroveratryl)naloxone, CNV-NLX), has been found to be a valuable biochemical probe. While the synthesis of CNV-NLX is simple, its characterization is complicated by the fact that it is produced as a mixture of αR,5R,9R,13S,14S and αS,5R,9R,13S,14S diastereomers. Using long-range and heteronuclear NMR correlations, the 1H NMR and 13C NMR resonances of both diastereomers have been fully assigned, confirming the structures. Monitoring of solutions of CNV-NLX in saline buffer, in methanol, and in DMSO has shown CNV-NLX to be stable for over a week under fluorescent laboratory lights at room temperature. Exposure of such solutions to λ 365 nm from a hand-held UV lamp led to the formation of naloxone and CNV-related breakdown products.
- 31 August 2017
- Published by Springer Nature in Metabolomics
- Vol. 13 (10) , 117
Synthesis and physicochemical characterization of the one-carbon carrier 10-formyltetrahydrofolate; a reference standard for metabolomics
Metabolomics analysis depends on the identification and validation of specific metabolites. This task is significantly hampered by the absence of well-characterized reference standards. The one-carbon carrier 10-formyltetrahydrofolate acts as a donor of formyl groups in anabolism, where it is a substrate in formyltransferase reactions in purine biosynthesis. It has been reported as an unstable substance and is currently unavailable as a reference standard for metabolomics analysis.
- 31 August 2017
- Published by Springer Nature in Metabolomics
- Vol. 13 (10) , 117
Synthesis and physicochemical characterization of the one-carbon carrier 10-formyltetrahydrofolate; a reference standard for metabolomics
Metabolomics analysis depends on the identification and validation of specific metabolites. This task is significantly hampered by the absence of well-characterized reference standards. The one-carbon carrier 10-formyltetrahydrofolate acts as a donor of formyl groups in anabolism, where it is a substrate in formyltransferase reactions in purine biosynthesis. It has been reported as an unstable substance and is currently unavailable as a reference standard for metabolomics analysis.
- 1 January 2013
- Published by Prompt Scientific Publishing
An Improved Synthetic Approach to Head-to-Tail Cyclic Tetrapeptides
- 1 January 2013
- Published by Prompt Scientific Publishing
An Improved Synthetic Approach to Head-to-Tail Cyclic Tetrapeptides
- 23 August 1996
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (4) , 603-612
Effects of sphingosine stereoisomers on P-glycoprotein phosphorylation and vinblastine accumulation in multidrug-resistant MCF-7 cells
- 23 August 1996
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (4) , 603-612
Effects of sphingosine stereoisomers on P-glycoprotein phosphorylation and vinblastine accumulation in multidrug-resistant MCF-7 cells